{"id":"W2341006816","doi":"10.1016/j.dadm.2016.03.002","title":"Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkers","year":2016,"lang":"en","type":"article","venue":"Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Norman Cousins Center for Psychoneuroimmunology; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; University of California, San Diego; Genentech; National Institutes of Health; Takeda Pharmaceutical Company; IXICO; H. Lundbeck A/S; Servier; Osteopathic Heritage Foundation; Eisai; Pfizer; Biogen; BioClinica; Rowan University; Parkinson Study Group; Northern California Institute for Research and Education; University of Southern California; Merck; GlaxoSmithKline; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; Novartis Pharmaceuticals Corporation; GE Healthcare; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics; AbbVie; Alzheimer's Association","keywords":"Autoantibody; Biomarker; Medicine; Disease; Receiver operating characteristic; Cognitive impairment; Internal medicine; Oncology; Dementia; Alzheimer's disease; Immunology; Antibody; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005718981,0.000738188,0.0006527973,0.0005906881,0.0006334392,0.0001345835,0.0001949518,0.00009976538,0.0003665304],"category_scores_gemma":[0.0002352208,0.000580009,0.0004959874,0.0004352035,0.0005141323,0.0006949727,0.0005181085,0.00018707,0.00002273479],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001580204,"about_ca_system_score_gemma":0.0008324712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001083973,"about_ca_topic_score_gemma":0.000002605133,"domain_scores_codex":[0.9945005,0.0004005467,0.0008992674,0.001289468,0.001857727,0.001052532],"domain_scores_gemma":[0.995262,0.0004024428,0.0005004074,0.0006131153,0.0005517978,0.002670279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003066509,0.003180103,0.9333432,0.0002793275,0.01037108,0.0004305514,0.00003054646,0.000003580857,0.01556553,0.00001571381,0.00005197091,0.03366195],"study_design_scores_gemma":[0.005758667,0.0006796611,0.8117032,0.003639288,0.04425627,0.000003117151,0.00009499557,0.0004261097,0.1326937,0.00006536457,0.0001154745,0.0005641796],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.939252,0.05527708,0.0003024418,0.001093591,0.0004346179,0.003167934,0.0002546994,0.0001644217,0.00005327045],"genre_scores_gemma":[0.9940318,0.002825893,0.0006977142,0.0001253588,0.0002627432,0.001809146,0.0001201967,0.000117163,0.00001000494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.12164,"threshold_uncertainty_score":0.9996651,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03596480791486187,"score_gpt":0.3689495537577416,"score_spread":0.3329847458428797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}